FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved Somerset Therapeutics, LLC's generic dihydroergotamine mesylate under an original ANDA for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)